In addition to CD36, there is evidence that the fatty acid transporter FATP4 (normally expressed at very low levels in the kidney) is a biomarker of poor prognosis in patients with ccRCC [84,85]. The gene discussed is CD36; the disease is nonpapillary renal cell carcinoma.